Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Internist (Berl) ; 61(3): 313-320, 2020 Mar.
Article in German | MEDLINE | ID: mdl-31965234

ABSTRACT

A 78-year-old woman with rheumatoid arthritis on TNF-α inhibitor, methotrexate and prednisolone presented with severe but unspecific symptoms such as leg weakness, shivering, bifrontal headache, nausea and staggering. The broad range of differential diagnoses lead to intricate and time-consuming diagnostic procedures. Serology, magnetic resonance imaging and microbiological investigations represent important steps to make the final diagnosis of cerebral toxoplasmosis. Both diagnostic approach and therapy require close cooperation of different disciplines. Therapies of rheumatoid arthritis as well as of toxoplasmosis are based on a long-term treatment and could be associated with numerous harmful side effects. Continuous monitoring and permanent adjustment of therapy regimes are therefore mandatory.


Subject(s)
Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Brain/diagnostic imaging , Immunosuppressive Agents/therapeutic use , Methotrexate/therapeutic use , Opportunistic Infections/diagnosis , Prednisolone/therapeutic use , Toxoplasmosis, Cerebral/diagnosis , Tumor Necrosis Factor-alpha/therapeutic use , Aged , Antirheumatic Agents/adverse effects , Brain/physiopathology , Diagnosis, Differential , Drug Therapy, Combination , Female , Humans , Immunosuppressive Agents/adverse effects , Magnetic Resonance Imaging/methods , Methotrexate/adverse effects , Prednisolone/adverse effects , Toxoplasmosis, Cerebral/diagnostic imaging , Toxoplasmosis, Cerebral/immunology , Toxoplasmosis, Cerebral/pathology , Treatment Outcome , Tumor Necrosis Factor-alpha/adverse effects
2.
Childs Nerv Syst ; 35(7): 1155-1157, 2019 07.
Article in English | MEDLINE | ID: mdl-31111179

ABSTRACT

INTRODUCTION: Shunt surgery in pediatric patients still bears a significant risk of infection, in addition to mechanical complications of the shunt system. Antibiotic-impregnated systems and perioperative antibiotics have been extensively studied for their potential to reduce shunt infections. We examined the effectiveness of intrawound application of vancomycin powder during shunt surgery. PATIENTS AND METHODS: Patient records of 78 primary shunt implantations at a mean age of 40 months were reviewed. In total, 52 patients (mean age 50 months) had been treated according to standard surgical and perioperative procedures (Std), whereas 26 patients (mean age 20 months) additionally had received topical application of vancomycin powder before wound closure (Vmc). Overall infection rate was 3.8%, in Std patients 5.8%, and in Vmc patients 0%. The rates of CSF fistula and revision surgery were similar in both groups (5.8% vs 8% and 23.1% vs. 30%, respectively). CONCLUSION: To the best of our knowledge, this is the first report on topical vancomycin instillation, indicating its efficacy for the prevention of shunt infection in pediatric patients. Further studies with a higher number of patients are needed to verify this finding.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cerebrospinal Fluid Shunts/adverse effects , Hydrocephalus/surgery , Surgical Wound Infection/prevention & control , Vancomycin/therapeutic use , Anti-Bacterial Agents/administration & dosage , Antibiotic Prophylaxis/methods , Child , Child, Preschool , Female , Humans , Infant , Male , Retrospective Studies , Vancomycin/administration & dosage
3.
Clin Neuroradiol ; 29(2): 341-349, 2019 Jun.
Article in English | MEDLINE | ID: mdl-29404621

ABSTRACT

Dural arteriovenous fistulas (DAVF) involving the anterior and posterior condylar vein at the skull base are rare but important to recognize. Due to the highly variable anatomy of the venous system of the skull base, detailed anatomical knowledge is essential for correct diagnosis and appropriate treatment of these lesions. In this report we review the normal anatomy of the condylar veins and describe rare and, to our knowledge, not previously reported anatomical variants. We also highlight the treatment modalities for these lesions with focus on the endovascular transvenous occlusion based on four consecutive cases from our center.


Subject(s)
Central Nervous System Vascular Malformations/therapy , Embolization, Therapeutic/methods , Aged , Cadaver , Central Nervous System Vascular Malformations/pathology , Cerebral Veins/abnormalities , Diagnosis, Differential , Humans , Magnetic Resonance Angiography , Male , Middle Aged
4.
Clin Neuroradiol ; 29(1): 125-133, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29080036

ABSTRACT

PURPOSE: There is a controversy concerning the risk of rupture of small intracranial aneurysms. We sought to determine the size and morphological features of ruptured intracranial aneurysms. MATERIAL AND METHODS: The hospital files and images from all patients referred during one decade (2007-2016) to a specialized neurovascular center were retrospectively reviewed. Neck diameter, fundus depth and width as well as neck width based on catheter angiography were measured. Aneurysm morphology was classified as either regular, lobulated, irregular or fusiform. RESULTS: A total of 694 consecutive patients with aneurysmal subarachnoid hemorrhage (aSAH) were identified (65.9% female, median age 54.3 years). The anterior communicating artery (AcomA) was the most frequent location of ruptured aneurysms. The medians for aneurysm depth, width and neck diameter were 5 mm, 4.5 mm and 3 mm, respectively. A regular contour of the aneurysm sac was found in 19%. CONCLUSION: The majority of aSAH are caused by small intracranial aneurysms. There is no safety margin in terms of small aneurysm size of regular shape without daughter aneurysms. Treatment should also be offered to patients with small, regularly shaped intracranial aneurysms, together with an empirical risk-benefit assessment.


Subject(s)
Aneurysm, Ruptured/pathology , Intracranial Aneurysm/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Aneurysm, Ruptured/complications , Aneurysm, Ruptured/diagnostic imaging , Child , Child, Preschool , Female , Humans , Infant , Intracranial Aneurysm/complications , Intracranial Aneurysm/diagnostic imaging , Male , Middle Aged , Neck/pathology , Retrospective Studies , Risk Assessment , Subarachnoid Hemorrhage/diagnostic imaging , Subarachnoid Hemorrhage/etiology , Time Factors , Young Adult
5.
Sci Rep ; 8(1): 13140, 2018 09 03.
Article in English | MEDLINE | ID: mdl-30177722

ABSTRACT

Woundhealing disorders characterized by impaired or delayed re-epithelialization are a serious medical problem that is painful and difficult to treat. Gelsolin (GSN), a known actin modulator, supports epithelial cell regeneration and apoptosis. The aim of this study was to estimate the potential of recombinant gelsolin (rhu-pGSN) for ocular surface regeneration to establish a novel therapy for delayed or complicated wound healing. We analyzed the influence of gelsolin on cell proliferation and wound healing in vitro, in vivo/ex vivo and by gene knockdown. Gelsolin is expressed in all tested tissues of the ocular system as shown by molecular analysis. The concentration of GSN is significantly increased in tear fluid samples of patients with dry eye disease. rhu-pGSN induces cell proliferation and faster wound healing in vitro as well as in vivo/ex vivo. TGF-ß dependent transcription of SMA is significantly decreased after GSN gene knockdown. Gelsolin is an inherent protein of the ocular system and is secreted into the tear fluid. Our results show a positive effect on corneal cell proliferation and wound healing. Furthermore, GSN regulates the synthesis of SMA in myofibroblasts, which establishes GSN as a key protein of TGF-ß dependent cell differentiation.


Subject(s)
Conjunctiva/metabolism , Cornea/metabolism , Dry Eye Syndromes/genetics , Gelsolin/genetics , Re-Epithelialization/genetics , Actins/genetics , Actins/metabolism , Animals , Cell Differentiation , Cell Proliferation , Conjunctiva/pathology , Cornea/pathology , Dry Eye Syndromes/blood , Dry Eye Syndromes/pathology , Epithelial Cells/cytology , Epithelial Cells/metabolism , Eyelids/cytology , Eyelids/metabolism , Female , Gelsolin/blood , Gene Expression Regulation , Humans , Lacrimal Apparatus/metabolism , Lacrimal Apparatus/pathology , Male , Mice , Myofibroblasts/cytology , Nasolacrimal Duct/cytology , Nasolacrimal Duct/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Wound Healing/genetics
6.
Ophthalmologe ; 114(10): 942-944, 2017 Oct.
Article in German | MEDLINE | ID: mdl-27975128

ABSTRACT

A 49-year-old female victim of violent crime with an acute bilateral loss of vision was referred to our hospital. The ophthalmological evaluation showed complete subconjunctival hemorrhage of both eyes, bilateral hemophthalmos and hypotonia of the left eye. These raised the suspicion of an occult scleral rupture. We immediately performed exploratory surgery and found a perforating scleral lesion of the left eye and a penetrating scleral lesion of the right eye. Furthermore, a small, cruciform wound was detected on the left temple. In cooperation with the department of radiology, the extraordinary injury pattern was reconstructed: a horizontal stab wound with perforation of the left eye and penetration of the right eye caused by a screwdriver. Visual rehabilitation necessitated further surgical interventions. Besides the intraoperative approach, immediate primary wound management within 100 h of trauma plays a pivotal role for long-term outcome.


Subject(s)
Blindness/etiology , Eye Hemorrhage/etiology , Eye Injuries, Penetrating/diagnosis , Eye Injuries/diagnosis , Violence , Wounds, Nonpenetrating/diagnosis , Blindness/surgery , Eye Hemorrhage/surgery , Eye Injuries/surgery , Eye Injuries, Penetrating/surgery , Facial Injuries/diagnosis , Facial Injuries/surgery , Female , Fluorescein Angiography , Follow-Up Studies , Humans , Laser Coagulation , Middle Aged , Multiple Trauma/diagnosis , Multiple Trauma/surgery , Postoperative Complications/diagnosis , Postoperative Complications/surgery , Reoperation , Sclera/injuries , Suture Techniques , Vitrectomy , Wounds, Nonpenetrating/surgery , Wounds, Stab/diagnosis , Wounds, Stab/surgery
9.
Cell Death Dis ; 6: e1726, 2015 Apr 16.
Article in English | MEDLINE | ID: mdl-25880093

ABSTRACT

Meibomian gland dysfunction is a leading cause of ocular surface disease. However, little is known about the regulatory processes that control the development and maintenance of this sebaceous gland. Here, we identify a novel function for CD147, a transmembrane protein that promotes tissue remodeling through induction of matrix metalloproteinases, in regulating meibocyte differentiation and activity. We found that CD147 localized along basal cells and within discrete membrane domains of differentiated meibocytes in glandular acini containing gelatinolytic activity. Induction of meibocyte differentiation in vitro promoted CD147 clustering and MMP9 secretion, whereas RNAi-mediated abrogation of CD147 impaired MMP9 secretion, concomitant with a reduction in the number of proliferative cells and cytoplasmic lipids. Meibomian glands of CD147 knockout mice had a lower number of acini in both the superior and inferior tarsal plates of the eyelids, and were characterized by loss of lipid-filled meibocytes compared with control mice. Together, our data provide evidence showing that gelatinolytic activity in meibocytes is dependent on CD147, and supports a role for CD147 in maintaining the normal development and function of the meibomian gland.


Subject(s)
Basigin/metabolism , Meibomian Glands/cytology , Meibomian Glands/metabolism , Animals , Cell Differentiation/physiology , Cell Proliferation , Epithelial Cells/cytology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Humans , Meibomian Glands/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout
SELECTION OF CITATIONS
SEARCH DETAIL
...